Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 26, 2022 at 03:06 pm IST
Suzhou Fushilai Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 141.78 million compared to CNY 115.05 million a year ago. Revenue was CNY 141.78 million compared to CNY 115.05 million a year ago. Net income was CNY 39.92 million compared to CNY 26.88 million a year ago. Basic earnings per share from continuing operations was CNY 0.58 compared to CNY 0.39 a year ago. Diluted earnings per share from continuing operations was CNY 0.58 compared to CNY 0.39 a year ago.